Toronto company whose speech analysis tools detect cognitive impairment, acquired by Cambridge Cognition in January 2023.
Founded in 2015 and headquartered in Toronto, Canada, Winterlight Labs Inc. develops speech-based cognitive assessments that detect impairment linked to dementia and mental illness. Its Winterlight Assessment extracts digital biomarkers from brief speech samples for life science research, clinical trials and senior care. Cambridge Cognition Limited acquired the company in January 2023 for GBP 7 million, made up of GBP 3 million in cash and GBP 4 million in shares. Winterlight has completed 4 deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in